Table 2 Parameter estimates and significance values for responses by statin regardless of Apo E status
From: Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
N | Mean | Standard error of the mean | p value | |
|---|---|---|---|---|
Age at death | ||||
Non statin | 1558 | 81.72 | 0.274 | 0.324 |
Statin | 258 | 81.07 | 0.530 | |
Duration of AD | ||||
Nonstatin | 1520 | 8.8053 | 0.11082 | 0.015 |
Statin | 256 | 8.0938 | 0.27669 | |
Age at onset of AD | ||||
Nonstatin | 1520 | 72.0526 | 0.29309 | 0.846 |
Statin | 256 | 72.1992 | v.57622 | |
Braak stage | ||||
Nonstatin | 1552 | 4.8853 | 0.03685 | 0.292 |
Statin | 258 | 4.7829 | 0.08682 | |
Total amyloid load | ||||
Nonstatin | 1557 | 2.3378 | 0.02420 | 0.635 |
Statin | 258 | 2.3682 | 0.05838 | |
Total tau load | ||||
Nonstatin | 1155 | 1.9957 | 0.01036 | 0.683 |
Statin | 193 | 1.9845 | 0.02595 | |